INHIBITORY POTENTIAL OF POLYHYDROXYLATED FULLERENES AGAINST PROTEIN TYROSINE PHOSPHATASE 1B

Area of Science:

• Biochemistry
• Nanotechnology
• Pharmacology

Background:

• Protein tyrosine phosphatase 1B (PTP1B) is a key regulator of cellular signaling pathways.
• Dysregulation of PTP1B is implicated in metabolic disorders like diabetes and obesity.
• Developing novel inhibitors for PTP1B is crucial for therapeutic interventions.

Purpose of the Study:

• To investigate the inhibitory effects of polyhydroxylated fullerenes on PTP1B.
• To elucidate the mechanism of PTP1B inhibition by fullerenols.
• To explore the structure-activity relationship between fullerene hydroxylation and inhibitory potency.

Main Methods:

• In silico molecular docking simulations.
• In vitro enzyme kinetics assays.
• Analysis of dose-dependent inhibition curves.

Main Results:

• Polyhydroxy fullerenes exhibit non-linear enzyme kinetics with PTP1B, suggesting positive cooperativity.
• Evidence indicates at least two binding sites for hydroxylated fullerene cages on PTP1B.
• Molecular docking reveals potential binding at both the active and allosteric sites of PTP1B.
• Inhibitory activity correlates with the degree of hydroxylation on fullerene nanoparticles.

Conclusions:

• Fullerenols act as allosteric inhibitors of PTP1B, with a mechanism involving positive cooperativity.
• The surface hydroxylation degree is a critical factor determining the efficacy of fullerene-based PTP1B inhibitors.
• These findings provide a mechanistic basis for designing novel fullerene derivatives as PTP1B modulators.